CpG-ODN TLR9 Agonists

CpG-ODNs are synthetic oligonucleotides designed to activate Toll-like receptor 9 (TLR9) and support immune response research. We offer CpG-ODN agonists and corresponding controls for research applications worldwide.

CpG-ODN

Product Details


Overview

Toll-like receptors (TLRs) recognize highly conserved structural motifs as one of the early innate immune responses to invading pathogens.  TLR 9 distinguishes mammalian and bacterial DNA and induces activation of immune cells.

A synthetic oligonucleotide containing a CpG motif has the effect of stimulating the immune system, promoting the maturation and activation of antigen-presenting cells, and the induction of Th1 and inflammatory cytokines.

  • Immune stimulation of potent and specific human and mouse immune cells, and for animal experiments
  • Offered in encapsulated vials in high purity
  • Guaranteed endotoxin 0.5 EU / mg or less
  • Easy handling

Product Details

TLR9 agonists of different classes have been shown to have different effects on cells. Please select the agonist that is best suited for your needs.

A-class TLR9 ligand: D35

  • Induction of high type I IFN production
  • Low activity against B cells
  • It is useful for activation of pDC and induction of IFN-α from PBMC, activation of IFN-signal pathway

B-class TLR9 ligand: K3

  • Stimulates B cells and activates TLR9-dependent NF-kB signal
  • Low activity for induction of FN-α
  • B-class is useful for activation of B cell, induction of IL-6 from human PBMC, activation of NF-kB signal pathway

CpG-ODN Activity evaluation

Example 1: Cytokine induction in human PBMC

Cytokine Production

Human IFN-a and IL-6 concentrations in culture supernatants were measured by ELISA for 24 hours after stimulation of human PBMC (1 x 106 cells) with 1 uM of each CpG. The bar graph shows the mean average ± SEM.

Example 2: Cytokine induction in mouse FL-DC

FL-DC Cytokine Production

Human IFN-a aMurine IFN-a and IL-6 concentrations in the culture supernatant of the mouse bone marrow-derived FL-DC (2 × 10 6 cells) induced to differentiate with FLT 3 L were stimulated with 1 uM of each CpG for 24 hours and then measured by ELISA. The bar graph shows the mean average ± SEM.

This data is provided as a result of collaborative research with Professor Ken Ishii and Professor Daiki Aoshi, Adjuvant Development Project of the National Institute of Pharmaceutical Sciences.

References:
1: Ishii KJ, Gursel I, Gursel M, Klinman DM. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.
Curr Opin Mol Ther. 2004 Apr; 6 (2): 166-74.
2: Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs.
J Immunol. 2001 Feb 15; 166 (4): 2372-7.

RNA purification examples include cultured cells, bacteria, plants, and yeast.

Contact Us Today To Discuss Your
Oligonucleotide Needs.

Need more information about these or other products? We are here to help.